With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
A new study in Nature Medicine highlights how processed foods disrupt gut health, while traditional Indian diets support ...
Health and Me on MSN
Weight loss diet: 6 filling Indian breakfast foods with less than 300 calories
If you are on a weight loss diet, then some incredible breakfast dishes in the Indian cuisine will not just satiate you but ...
Weight loss is not just about calories. A nutritionist explains how hormones like insulin, cortisol and estrogen may be ...
Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.
The Government of India has tightened regulation of GLP-1 drugs used for diabetes and weight loss, restricting prescriptions ...
8dOpinion
Generic versions of weight-loss drugs are a bulky opportunity for Chinese and Indian drugmakers
The simultaneous patent expiry of Ozempic in China and India has seen generic makers jump in. Low cost production in high ...
It is not just about calories; these hormones could be quietly influencing your weight loss journey ...
A deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost ...
Wegovy launched in India in 2025, but the patent on its core ingredient expires in the country this week India could soon get a lot thinner - at least in theory. On Friday the patent on semaglutide - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results